Skip to content

A clinical research for dampness-heat stagnancy combined treatment of metabolic syndrome with hypertension

A clinical research for dampness-heat stagnancy combined treatment of metabolic syndrome with hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018830
Enrollment
Unknown
Registered
2018-10-12
Start date
2018-10-31
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Group 1:Chinese herb formula combined routine convenience medical treatment
Group 2:routine convenience medical treatment

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18-80 years; 2. fit with two of the following items: central obesity with waistline=90cm(male), or >=85cm(female), fasting glucose=6.1mmol/L or postprandial glucoseand=7.8mmol/L and/or diagnosis with diabetes, TG>=1.70mmol/L (150mg/dl), HDL-c=140/90mmHg and/or diagnosis with hypertension; 4. subjects who has signed the informed consent

Exclusion criteria

Exclusion criteria: 1. hypertension crisis; 2. SBP>180mmHg, DBP>110mmHg; 3. secondary hypertension(renal parenchymal hypertension, renovascular hypertension, primary aldosteronism, pheochromocytoma, hypercortisolism, aortic coarctation, hypertension of pregnancy); 4. Secondary Obesity (thalamus fat, pituitary fat, Low thyroid function of obesity, Cushing syndrome); 5. The hypertension and obesity caused by drugs such as oral contraceptive, hormone therapy; 6. serious liver ang kidney damage, subjects with tumor, pregnant or lactating women, subjects with mental sickness, allergic to experimental drugs or any composition of the drug, treated by diet pills in recent 3 months.

Design outcomes

Primary

MeasureTime frame
blood pressure, 24-hour ambulatory blood pressure;pulse wave velocity (PWV), ankle brachial index (ABI);

Secondary

MeasureTime frame
waist circumference, waist-hip ratio, body mass index(BMI);blood glucose, glycosylated hemoglobin, insulin, HOMA-IR;cholesterol, glycerin trilaurate, high density lipoprotein, low density lipoprotein;Urine microalbuminuria creatinine ratio, 24-hour urinary protein, eGFR;

Countries

China

Contacts

Public ContactWang Tian-Zhan

Shanghai Sixth People's Hospital

jason_tiger@163.com+86 13482540171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026